Mintz advised Cardurion Pharmaceuticals on the deal. Cardurion Pharmaceuticals, Inc. (Cardurion), a clinical-stage biotechnology company, announced a private investment of up to $300 million from Bain Capital...
This content is for Standard 1 Year members only. LoginJoin Now